how does a glp 1 receptor agonist work GLP-1 agonists for individualized treatment of type 2 diabetes mellitus “Weighing In” on GLP-1 Receptor

According to FDA, GLP-1RA had not shown evident risk of pancreatitis and pancreatic tumor (111)

[DOI] [PMC free article] [PubMed] [Google Scholar] 102.Darpo B, Philip S, MacConell L, Cirincione B, Mitchell M, Han J, Huang W, Malloy J, Schulteis C, Shen L, Porter L

They work through several important mechanisms: They increase insulin release from the pancreas when blood glucose is high They reduce excess glucose release from the liver They slow stomach emptying, helping prevent sharp glucose spikes after meals They increase feelings of fullness, often reducing appetite Because these effects depend on blood glucose levels, GLP-1 medications on their own carry a very low risk of causing low blood sugar (hypoglycaemia)

High glucose promotes the progression of colorectal cancer by activating the BMP4 signaling and inhibited by glucagon-like peptide-1 receptor agonist